Does vortioxetine (Trintellix) cause night sweats, and how can night sweats be differentiated in a perimenopausal woman who has just started the medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Trintellix Cause Night Sweats?

Yes, Trintellix (vortioxetine) can cause night sweats as it belongs to the SSRI class of antidepressants, which are recognized pharmaceutical causes of sweating. 1, 2

Evidence for SSRI-Induced Sweating

The Endocrine Society Clinical Practice Guideline explicitly lists SSRIs as a pharmaceutical cause of sweats in their differential diagnosis table for vasomotor symptoms 1. The FDA label for Trintellix lists sweating as a potential side effect, particularly in the context of serotonin syndrome and discontinuation syndrome 2. While "night sweats" is not specifically itemized as a standalone adverse effect in the FDA label, sweating is clearly documented as occurring with this medication.

Differentiating Drug-Induced vs. Menopausal Night Sweats

Timing is Critical

The key differentiating factor is temporal relationship: drug-induced sweating typically begins within days to weeks after starting the medication, whereas menopausal vasomotor symptoms usually predate medication initiation or have been ongoing. 1, 3

Clinical Characteristics to Assess

Menopausal night sweats 1:

  • Begin with sudden sensation of heat centered on upper chest and face
  • Rapidly become generalized when moderate-to-severe
  • Last 2-4 minutes per episode
  • Associated with profuse perspiration, palpitations, or anxiety
  • More common during first 4 hours of sleep
  • May have triggers (spicy food, alcohol)
  • Often accompanied by daytime hot flashes

SSRI-induced sweating 4:

  • Can occur primarily on head and back of neck (though can be generalized)
  • May be more continuous or frequent rather than discrete 2-4 minute episodes
  • Typically not preceded by sensation of heat/flushing
  • Less likely to have specific triggers like food or alcohol
  • May occur throughout the night rather than clustering in first 4 hours

Diagnostic Algorithm

  1. Establish baseline symptom timeline: Did night sweats exist before starting Trintellix? If yes, likely menopausal. If they started within 1-8 weeks of initiating Trintellix, suspect drug-induced component 4.

  2. Assess symptom pattern:

    • Discrete 2-4 minute episodes with heat sensation = more likely menopausal 1
    • Continuous or frequent sweating without heat waves = more likely drug-induced 4
  3. Check for daytime hot flashes: Presence strongly suggests menopausal etiology, as approximately 75% of perimenopausal women experience these 1

  4. Consider a therapeutic trial: If symptoms are new or worsened since starting Trintellix and are bothersome:

    • Dose reduction of Trintellix may help if drug-induced 4
    • Symptoms should improve within 2-5 weeks if drug-related 4
    • If no improvement, more likely menopausal

Common Pitfall to Avoid

Do not assume all night sweats in a perimenopausal woman are menopausal. The guideline specifically warns that SSRIs cause sweats 1, and this can be overlooked when a woman is in the expected age range for menopause. Both etiologies can coexist, potentially requiring management of both the depression and vasomotor symptoms.

Management Considerations

If drug-induced sweating is confirmed or suspected 4:

  • Consider dose reduction of Trintellix
  • If ineffective, consider switching to a different antidepressant class
  • Adjunctive agents like benztropine or cyproheptadine can treat sweating symptoms if antidepressant cannot be changed

If menopausal etiology is confirmed 1:

  • Hormone therapy is most effective for vasomotor symptoms
  • Interestingly, one preliminary study showed vortioxetine itself improved hot flash frequency and severity in perimenopausal women with depression 5, though this requires further validation

The presence of both conditions simultaneously is possible and may require addressing both the antidepressant choice and menopausal symptoms independently.

References

Guideline

treatment of symptoms of the menopause: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

Research

Persistent Night Sweats: Diagnostic Evaluation.

American family physician, 2020

Research

Antidepressant-induced sweating.

The Annals of pharmacotherapy, 2005

Research

Vortioxetine for major depressive disorder, vasomotor, and cognitive symptoms associated with the menopausal transition.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.